Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Apr;84(8):1070–1075. doi: 10.1054/bjoc.2001.1728

Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations

M Nordsmark 1,2, J Alsner 1, J Keller 3, O S Nielsen 2, O M Jensen 4, M R Horsman 1, J Overgaard 1
PMCID: PMC2363869  PMID: 11308256

Abstract

Clinical and experimental studies have suggested that tumour hypoxia is associated with poor treatment outcome and that loss of apoptotic potential may play a role in malignant progression of neoplastic cells. The tumour suppressor gene p53 induces apoptosis under certain conditions and microenvironmental tumour hypoxia may select for mutant tumour cells with diminished apoptotic potential due to lack of p53 function. The aim of this study was to evaluate the prognostic relevance of oxygenation status for treatment outcome and to compare pre-treatment tumour oxygenation measurements were done in 31 of those by PCR using DNA extracted from paraffin-embaedded sections (n = 2) or frozen biopsies (n = 29). The overall median of the tumour median pO 2 was 19 mmHg (range 1–58 mmHg). Only 6 tumours had functional p53 mutations and no association was found between mutant p53 and tumour hypoxia. Five out of 6 STS with lower histopathological grade were well-oxygenated whereas high-grade STS were both hypoxic and well-oxygenated. At a median follow-up of 74 months, 16 patients were still alive among 28 available for survival analysis. When stratifying into hypoxic and well-oxygenated tumours patients with the most hypoxic tumours has a statistically poorer disease-specific and overall survival at 5 years. In conclusion hypoxia was an indicator for both a poorer disease specific and overall survival in human STS but hypoxic tumours were not characterized by mutations in the p53 gene. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: soft tissue sarcoma, p53, hypoxia, polarographic oxygen electrode, tumour oxygenation, predictive assay, survival

Full Text

The Full Text of this article is available as a PDF (73.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam M. F., Gabalski E. C., Bloch D. A., Oehlert J. W., Brown J. M., Elsaid A. A., Pinto H. A., Terris D. J. Tissue oxygen distribution in head and neck cancer patients. Head Neck. 1999 Mar;21(2):146–153. doi: 10.1002/(sici)1097-0347(199903)21:2<146::aid-hed8>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  2. Birner P., Schindl M., Obermair A., Plank C., Breitenecker G., Oberhuber G. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 2000 Sep 1;60(17):4693–4696. [PubMed] [Google Scholar]
  3. Brizel D. M., Dodge R. K., Clough R. W., Dewhirst M. W. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol. 1999 Nov;53(2):113–117. doi: 10.1016/s0167-8140(99)00102-4. [DOI] [PubMed] [Google Scholar]
  4. Brizel D. M., Scully S. P., Harrelson J. M., Layfield L. J., Bean J. M., Prosnitz L. R., Dewhirst M. W. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 1996 Mar 1;56(5):941–943. [PubMed] [Google Scholar]
  5. Cho Y., Gorina S., Jeffrey P. D., Pavletich N. P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science. 1994 Jul 15;265(5170):346–355. doi: 10.1126/science.8023157. [DOI] [PubMed] [Google Scholar]
  6. Dachs G. U., Tozer G. M. Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur J Cancer. 2000 Aug;36(13 Spec No):1649–1660. doi: 10.1016/s0959-8049(00)00159-3. [DOI] [PubMed] [Google Scholar]
  7. Di Como C. J., Prives C. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay. Oncogene. 1998 May 14;16(19):2527–2539. doi: 10.1038/sj.onc.1202041. [DOI] [PubMed] [Google Scholar]
  8. Durand R. E. Keynote address: the influence of microenvironmental factors on the activity of radiation and drugs. Int J Radiat Oncol Biol Phys. 1991 Feb;20(2):253–258. doi: 10.1016/0360-3016(91)90100-i. [DOI] [PubMed] [Google Scholar]
  9. Fyles A. W., Milosevic M., Wong R., Kavanagh M. C., Pintilie M., Sun A., Chapman W., Levin W., Manchul L., Keane T. J. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol. 1998 Aug;48(2):149–156. doi: 10.1016/s0167-8140(98)00044-9. [DOI] [PubMed] [Google Scholar]
  10. Graeber T. G., Osmanian C., Jacks T., Housman D. E., Koch C. J., Lowe S. W., Giaccia A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 1996 Jan 4;379(6560):88–91. doi: 10.1038/379088a0. [DOI] [PubMed] [Google Scholar]
  11. Guldberg P., Nedergaard T., Nielsen H. J., Olsen A. C., Ahrenkiel V., Zeuthen J. Single-step DGGE-based mutation scanning of the p53 gene: application to genetic diagnosis of colorectal cancer. Hum Mutat. 1997;9(4):348–355. doi: 10.1002/(SICI)1098-1004(1997)9:4<348::AID-HUMU8>3.0.CO;2-1. [DOI] [PubMed] [Google Scholar]
  12. Hockel M., Schlenger K., Aral B., Mitze M., Schaffer U., Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996 Oct 1;56(19):4509–4515. [PubMed] [Google Scholar]
  13. Hohenberger P., Felgner C., Haensch W., Schlag P. M. Tumor oxygenation correlates with molecular growth determinants in breast cancer. Breast Cancer Res Treat. 1998 Mar;48(2):97–106. doi: 10.1023/a:1005921513083. [DOI] [PubMed] [Google Scholar]
  14. Höckel M., Schlenger K., Höckel S., Vaupel P. Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res. 1999 Sep 15;59(18):4525–4528. [PubMed] [Google Scholar]
  15. Jensen O. M., Høgh J., Ostgaard S. E., Nordentoft A. M., Sneppen O. Histopathological grading of soft tissue tumours. Prognostic significance in a prospective study of 278 consecutive cases. J Pathol. 1991 Jan;163(1):19–24. doi: 10.1002/path.1711630105. [DOI] [PubMed] [Google Scholar]
  16. Knocke T. H., Weitmann H. D., Feldmann H. J., Selzer E., Pötter R. Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. Radiother Oncol. 1999 Nov;53(2):99–104. doi: 10.1016/s0167-8140(99)00139-5. [DOI] [PubMed] [Google Scholar]
  17. Moulder J. E., Rockwell S. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys. 1984 May;10(5):695–712. doi: 10.1016/0360-3016(84)90301-8. [DOI] [PubMed] [Google Scholar]
  18. Nordsmark M., Bentzen S. M., Overgaard J. Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity. Acta Oncol. 1994;33(4):383–389. doi: 10.3109/02841869409098433. [DOI] [PubMed] [Google Scholar]
  19. Nordsmark M., Høyer M., Keller J., Nielsen O. S., Jensen O. M., Overgaard J. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 1996 Jul 1;35(4):701–708. doi: 10.1016/0360-3016(96)00132-0. [DOI] [PubMed] [Google Scholar]
  20. Nordsmark M., Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol. 2000 Oct;57(1):39–43. doi: 10.1016/s0167-8140(00)00223-1. [DOI] [PubMed] [Google Scholar]
  21. Nordsmark M., Overgaard M., Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 1996 Oct;41(1):31–39. doi: 10.1016/s0167-8140(96)91811-3. [DOI] [PubMed] [Google Scholar]
  22. Rudat V., Vanselow B., Wollensack P., Bettscheider C., Osman-Ahmet S., Eble M. J., Dietz A. Repeatability and prognostic impact of the pretreatment pO(2) histography in patients with advanced head and neck cancer. Radiother Oncol. 2000 Oct;57(1):31–37. doi: 10.1016/s0167-8140(00)00200-0. [DOI] [PubMed] [Google Scholar]
  23. Stackpole C. W., Groszek L., Kalbag S. S. Benign-to-malignant B16 melanoma progression induced in two stages in vitro by exposure to hypoxia. J Natl Cancer Inst. 1994 Mar 2;86(5):361–367. doi: 10.1093/jnci/86.5.361. [DOI] [PubMed] [Google Scholar]
  24. Stadler P., Becker A., Feldmann H. J., Hänsgen G., Dunst J., Würschmidt F., Molls M. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 1999 Jul 1;44(4):749–754. doi: 10.1016/s0360-3016(99)00115-7. [DOI] [PubMed] [Google Scholar]
  25. Sundfør K., Lyng H., Tropé C. G., Rofstad E. K. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization. Radiother Oncol. 2000 Feb;54(2):101–107. doi: 10.1016/s0167-8140(99)00175-9. [DOI] [PubMed] [Google Scholar]
  26. Sutherland RM, Ausserer WA, Murphy BJ, Laderoute KR. Tumor Hypoxia and Heterogeneity: Challenges and Opportunities for the Future. Semin Radiat Oncol. 1996 Jan;6(1):59–70. doi: 10.1053/SRAO0060059. [DOI] [PubMed] [Google Scholar]
  27. Vaupel P., Schlenger K., Knoop C., Höckel M. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res. 1991 Jun 15;51(12):3316–3322. [PubMed] [Google Scholar]
  28. Vogelstein B., Lane D., Levine A. J. Surfing the p53 network. Nature. 2000 Nov 16;408(6810):307–310. doi: 10.1038/35042675. [DOI] [PubMed] [Google Scholar]
  29. Vraa S., Keller J., Nielsen O. S., Sneppen O., Jurik A. G., Jensen O. M. Prognostic factors in soft tissue sarcomas: the Aarhus experience. Eur J Cancer. 1998 Nov;34(12):1876–1882. doi: 10.1016/s0959-8049(98)00233-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES